{
    "id": 3499,
    "fullName": "MTOR F1888L",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MTOR F1888L lies within the central FAT domain of the Mtor protein (PMID: 17684489). F1888L confers a gain of function to the Mtor protein resulting in activation of signaling and phosphorylation of downstream targets (PMID: 24631838).",
            "references": [
                {
                    "id": 2032,
                    "pubMedId": 17684489,
                    "title": "Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17684489"
                },
                {
                    "id": 1953,
                    "pubMedId": 24631838,
                    "title": "A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24631838"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2475,
        "geneSymbol": "MTOR",
        "terms": [
            "MTOR",
            "FRAP",
            "FRAP1",
            "FRAP2",
            "RAFT1",
            "RAPT1",
            "SKS"
        ]
    },
    "variant": "F1888L",
    "createDate": "03/04/2015",
    "updateDate": "03/04/2015",
    "referenceTranscriptCoordinates": {
        "id": 145205,
        "transcript": "NM_004958",
        "gDna": "chr1:g.11129790A>G",
        "cDna": "c.5662T>C",
        "protein": "p.F1888L",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 8826,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing MTOR F1888L treated with Rapamune (sirolimus) in culture demonstrated decreased phosphorylation of S6k, suggesting sensitivity (PMID: 27482884).",
            "molecularProfile": {
                "id": 3305,
                "profileName": "MTOR F1888L"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6761,
                    "pubMedId": 27482884,
                    "title": "Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27482884"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 8830,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing the double mutant, MTOR F1888L and MTOR L2230V, demonstrated resistance to Rapamune (sirolimus) in culture (PMID: 27482884).",
            "molecularProfile": {
                "id": 26458,
                "profileName": "MTOR F1888L MTOR L2230V"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 6761,
                    "pubMedId": 27482884,
                    "title": "Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27482884"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3305,
            "profileName": "MTOR F1888L",
            "profileTreatmentApproaches": [
                {
                    "id": 2834,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "MTOR F1888L"
                },
                {
                    "id": 2833,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "MTOR F1888L"
                },
                {
                    "id": 684,
                    "name": "mTOR Inhibitor",
                    "profileName": "MTOR F1888L"
                }
            ]
        },
        {
            "id": 26458,
            "profileName": "MTOR F1888L MTOR L2230V",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 145205,
            "transcript": "NM_004958",
            "gDna": "chr1:g.11129790A>G",
            "cDna": "c.5662T>C",
            "protein": "p.F1888L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 145206,
            "transcript": "XM_005263438",
            "gDna": "chr1:g.11129790A>G",
            "cDna": "c.5662T>C",
            "protein": "p.F1888L",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}